CLARKSON UNIVERSITY Memorandum September 2019
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ADHD Parents Medication Guide Revised July 2013
ADHD Parents Medication Guide Revised July 2013 Attention-Deficit/Hyperactivity Disorder Prepared by: American Academy of Child & Adolescent Psychiatry and American Psychiatric Association Supported by the Elaine Schlosser Lewis Fund Physician: ___________________________________________________ Address: ___________________________________________________ ___________________________________________________ ___________________________________________________ Phone: ___________________________________________________ Email: ___________________________________________________ ADHD Parents Medication Guide – July 2013 2 Introduction Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by difficulty paying attention, excessive activity, and impulsivity (acting before you think). ADHD is usually identified when children are in grade school but can be diagnosed at any time from preschool to adulthood. Recent studies indicate that almost 10 percent of children between the ages of 4 to 17 are reported by their parents as being diagnosed with ADHD. So in a classroom of 30 children, two to three children may have ADHD.1,2,3,4,5 Short attention spans and high levels of activity are a normal part of childhood. For children with ADHD, these behaviors are excessive, inappropriate for their age, and interfere with daily functioning at home, school, and with peers. Some children with ADHD only have problems with attention; other children only have issues with hyperactivity and impulsivity; most children with ADHD have problems with all three. As they grow into adolescence and young adulthood, children with ADHD may become less hyperactive yet continue to have significant problems with distraction, disorganization, and poor impulse control. ADHD can interfere with a child’s ability to perform in school, do homework, follow rules, and develop and maintain peer relationships. When children become adolescents, ADHD can increase their risk of dropping out of school or having disciplinary problems. -
August 2014 Medical Marijuana and Your Workforce - Part III Drug Tests, Zero Tolerance Policies and Unemployment Compensation
LAW OFFICE OF LORI A. GOLDSTEIN, LLC CLIENT BULLETIN August 2014 Medical Marijuana and Your Workforce - Part III Drug Tests, Zero Tolerance Policies and Unemployment Compensation This is the final in a three-part series covering the new Illinois Compassionate Use of Medical Cannabis Pilot Program Act and what it means for employers. Drug Testing Until the Illinois courts provide more guidance, employers should proceed with caution when a registered patient tests positive for marijuana on a pre-employment or employee drug screening. Since cannabis can remain in the body for several weeks, a positive drug test does not necessarily mean that an applicant or employee is impaired at the time of the test. Employers must be careful not to reject a registered patient’s application based solely based on a positive drug test, unless hiring the applicant presents a public safety risk (e.g., security guard or driver positions). Evaluate drug test results for registered patient employees on a case-by-case basis, permitting the employee to explain or contest the basis of a positive test result. Zero Tolerance Policies and Privacy Laws Can employers in states legalizing marijuana include marijuana in zero tolerance drug policies? How are privacy rights affected? Many states, including Illinois, forbid employers from terminating employees for lawful activities conducted during nonworking hours (Illinois Right to Privacy in the Workplace Act.) But if the Illinois courts follow the courts of other states, employers will have more freedom to discipline a registered patient who tests positive for marijuana. The Colorado Supreme Court will soon be considering this issue. -
Sample Drug-Free Workplace Policy Acknowledgement Statement for Your Employees to Sign
DRUG-FREE WORKPLACE POLICY 2 DISCLAIMER DISCLAIMER: Pinnacol Assurance is providing this resource for informational purposes only. It is not designed for use by any reader, business or enterprise, nor is this intended to be legal advice on what a drug policy should or should not contain. This sample policy is designed to be illustrative of the types of policies used and is written in general terms, without specific consideration given to individual needs or circumstances. Provisions included may not be applicable to the specific reader or business situation, and specific provisions that are applicable may have been omitted from this sample. These materials are not to be used as a substitute for legal or management advice on what is necessary for a valid, binding drug policy. Pinnacol will not be held responsible for any consequences arising out of the use of this sample document, and recommends that before implementing a drug policy advice be obtained from a learned professional knowledgeable in this area. INTRODUCTION 3 At Pinnacol Assurance, we are committed to helping you protect the safety and health of your employees. One way to protect your employees and mitigate risk is by establishing a drug-free workplace policy. This resource was designed to help you design, implement and enforce a drug-free workplace policy. When creating a drug-free workplace policy, consider the following: n What is the purpose of this program and policy? n Who is responsible for enforcing the policy? n Is this a zero-tolerance policy? n How is the policy communicated to your employees? n Who is covered by this policy? n What are the consequences for violating the policy? n What are your employees required to tell you? n Do you offer any type of employee assistance to n Does the policy include drug testing? employees who need help? n Does the policy include searches? Portions of the sample policy contained in this book have been pulled from the elaws section of the U.S. -
Should Per Se Limits Be Imposed for Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns
HUMBOLDT JOURNAL OF SOCIAL RELATIONS—ISSUE 35, 2013 Should Per Se Limits Be Imposed For Cannabis? Equating Cannabinoid Blood Concentrations with Actual Driver Impairment: Practical Limitations and Concerns Paul Armentano National Organization for the Reform of Marijuana Laws [email protected] ________________________________________________________________________ Abstract Fourteen US states have amended their longstanding, effect-based DUI drug laws to per se or zero tolerant per se statutes in regard to cannabis. Other states are considering enacting similar legislation. Under these amended traffic safety laws, it is a criminal violation for one to operate a motor vehicle with trace levels of cannabinoids or their metabolites in his or her blood or urine. Opponents of per se cannabinoid limits argue that neither the presence of cannabinoids nor their metabolites are appropriate or consistent predictors of behavioral or psychomotor impairment. They further argue that the imposition of such per se limits may result in the criminal conviction of individuals who may have previously consumed cannabis at some unspecified point in time, but were no longer under its influence. As more states enact statutory changes allowing for the legal use of cannabis under certain circumstances, there is a growing need to re-examine the appropriateness of these proposed per se standards for cannabinoids and their metabolites because the imposition of such limits may, in some instances, inadvertently criminalize behavior that poses no threat to traffic safety, -
Adhd Labeling and Treatment of Children in Japan 1
CCHR REPORT: ADHD LABELING AND TREATMENT OF CHILDREN IN JAPAN 1 2018 ADHD labeling and treatment of children in Japan CITIZENS COMMISSION ON HUMAN RIGHTS JAPAN CITIZENS COMMISSION ON HUMAN RIGHTS EUROPE January 2018 CCHR REPORT: ADHD LABELING AND TREATMENT OF CHILDREN IN JAPAN 2 CCHR REPORT: ADHD LABELING AND TREATMENT OF CHILDREN IN JAPAN 3 Introduction Children in Japan are being labeled with the psychiatric diagnosis attention- deficit/hyperactivity disorder (ADHD) and given psychiatric drugs in order to control the symptoms labeled as ADHD, just as in many European and American countries. The rate of the drugs used are different than those in Europe and the USA which is caused mainly by earlier abuses of psychostimulant drugs causing some of these to be banned and secondly a zero tolerance to drugs use in general (the psychostimulants used in the control of ADHD labeled children are actual drugs with a high abuse potential). Large international pharmaceuticals are increasingly focusing on releasing new types of drugs on the Japanese market that can be prescribed to children labelled with ADHD such as lisdexamfetamine and guanfacine (sold under the name Intuniv). The Japanese market is being described as “the world’s third-biggest market for ADHD treatments” and is growing at more than 20 percent annually.1 Japanese children in early studies were found to be among those less considered fulfilling the diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD). Yet, marketing efforts and American psychiatrists have promoted the American concept of various behavioural symptoms clustered together and called ADHD, to a degree, that a large number of parents have taken on the concept. -
Teenage Drinking and Driving
State of Illinois For more information, Illinois State Police or to request a safety ZERO TOLERANCE LAW presentation, you for Underage Drinking may send an email to the Teenage and Driving ISP Safety Zero Tolerance is a state law that went into effect on Education Unit at: Drinking and January 1, 1995, and provides for the suspension of driving privileges of any person under the age of 21 Safety_Education@isp. who drives after consuming alcohol. As the name Driving Zero Tolerance suggests, any trace of alcohol in a state.il.us young person’s system can result in a suspended or call 217/782-6637 driver’s license. Possession or Consumption You can also visit us on of Alcoholic Beverages the web at: It is illegal for any person under the age of 21 to www.state.il.us/safety/ consume or possess, whether opened or unopened, alcoholic beverages. Penalties include: eduprogs.cfm • Driving privileges suspended for 6 months for a first conviction. • Driving privileges suspended for 12 months for a second conviction. • A maximum $2,500 fine and up to one year in jail. Improper Use of Illinois Driver’s License or ID Card You could spend up to three years in prison, face fines of up to $25,000, and have your driver’s license suspended if you: • Allow another to use your driver’s license or ID Card. • Use someone else’s driver’s license or ID Card to represent yourself. Printed by the Authority of the State of Illinois ISP Central Printing Section • Knowingly possess a fictitious or unlawfully altered Illinois State Police driver’s license or ID Card. -
Drug-Related Crime
NT OF ME J T US U.S. Department of Justice R T A I P C E E D B O J C S Office of Justice Programs F A V M F O I N A C IJ S R E BJ G O OJJDP O F PR Bureau of Justice Statistics JUSTICE Drugs & Crime Data September 1994, NCJ–149286 Fact Sheet: Drug-Related Crime Drugs are related to crime in multiple ways. Most This fact sheet will focus on the second and third catego- directly, it is a crime to use, possess, manufacture, or ries. Drug-related offenses and a drug-using lifestyle are distribute drugs classified as having a potential for abuse. major contributors to the U.S. crime problem. Cocaine, heroin, marijuana, and amphetamines are examples of drugs classified to have abuse potential. Drug users in the general population are more Drugs are also related to crime through the effects they likely than nonusers to commit crimes have on the user’s behavior and by generating violence and other illegal activity in connection with drug traffick- The U.S. Department of Health and Human Services ing. The following scheme summarizes the various ways (HHS) National Household Survey on Drug Abuse asks that drugs and crime are related. individuals living in households about their drug and alcohol use and their involvement in acts that could get Summary of drugs/crime relationship them in trouble with the police. Provisional data for 1991 show that among adult respondents (ages 18–49), those Drugs and crime who use cannabis (marijuana) or cocaine were much more relationship Definition Examples likely to commit crimes of all types than those who did Drug-defined Violations of laws Drug possession or offenses prohibiting or reg- use. -
Drugs and Crime Facts
U.S. Department of Justice Office of Justice Programs Bureau of Justice Statistics Drugs and Crime Facts By Tina L. Dorsey BJS Editor Priscilla Middleton BJS Digital Information Specialist NCJ 165148 U.S. Department of Justice Office of Justice Programs 810 Seventh Street, N.W. Washington, D.C. 20531 Eric H. Holder, Jr. Attorney General Office of Justice Programs Partnerships for Safer Communities Laurie O. Robinson Acting Assistant Attorney General World Wide Web site: http//www.ojp.usdoj.gov Bureau of Justice Statistics Michael D. Sinclair Acting Director World Wide Web site: http://www.ojp.usdoj.gov/bjs For information contact National Criminal Justice Reference Service 1-800-851-3420 BJS: Bureau of Justice Statistics Drugs and Crime Facts Drugs & Crime Facts This site summarizes U.S. statistics about drug-related crimes, law enforcement, courts, and corrections from Bureau of Justice Statistics (BJS) and non-BJS sources (See Drug data produced by BJS below). It updates the information published in Drugs and Crime Facts, 1994, (NCJ 154043) and will be revised as new information becomes available. The data provide policymakers, criminal justice practitioners, researchers, and the general public with online access to understandable information on various drug law violations and drug-related law enforcement. Contents Drug use and crime Drug law violations Enforcement (arrests, seizures, and operations) Pretrial release, prosecution, and adjudication Correctional populations and facilities Drug treatment under correctional supervision Drug control budget Drug use (by youth and the general population) Public opinion about drugs Bibliography To ease printing, a consolidated version in Adobe Acrobat format (669 KB) of all of the web pages in Drugs & Crime Facts is available for downloading. -
Japan 2020 Crime & Safety Report
Japan 2020 Crime & Safety Report This is an annual report produced in conjunction with the Regional Security Office at the U.S. Embassy in Tokyo. OSAC encourages travelers to use this report to gain baseline knowledge of security conditions in Japan. For more in-depth information, review OSAC’s Japan country page for original OSAC reporting, consular messages, and contact information, some of which may be available only to private-sector representatives with an OSAC password. Travel Advisory The current U.S. Department of State Travel Advisory at the date of this report’s publication assesses Japan at Level 2, indicating travelers should exercise increased caution due to due to an outbreak of COVID-19. Prior to the COVID-19 pandemic, Japan’s Travel Advisory was assessed as a Level 1. Review OSAC’s report, Understanding the Consular Travel Advisory System. Overall Crime and Safety Situation Crime Threats The U.S. Department of State has assessed all cities with U.S. diplomatic posts in Japan as being LOW- threat locations for crime directed at or affecting official U.S. government interests. The crime rate in Japan is generally well below the U.S. national average. Crimes targeting foreigners are seldom, especially as Tokyo has touted itself as “the world’s safest big city” in preparation for the now-postponed 2020 Olympic Games. The Economist Intelligence Unit ranked Tokyo and Osaka as the world’s number one and number three safest cities for 2019. Pickpocketing and other petty crimes do sometimes take place in crowded shopping areas, bars and nightclubs, and public transportation hubs. -
Improving the Measurement of Drug-Related Crime
Improving the Measurement of Drug-Related Crime 2013 Improving the Measurement of Drug-Related Crime Office of National Drug Control Policy Executive Office of the President Washington, DC October 2013 Acknowledgements This publication was sponsored by the Office of National Drug Control Policy (ONDCP), Executive Office of the President, under contract number HHSP23320095649WC_ HHSP23337017T to the RAND Corporation. The authors of this report are Rosalie Liccardo Pacula, Russell Lundberg, Jonathan P. Caulkins, Beau Kilmer, Sarah Greathouse, Terry Fain, and Paul Steinberg from the RAND Drug Policy Research Center. M. Fe Caces served as the ONDCP Task Order Officer. This work was significantly improved by input from an expert panel, which consisted of Allen Beck, Al Blumstein, Henry Brownstein, Rick Harwood, Paul Heaton, Mark Kleiman, Ted Miller, Nancy Rodriquez, Gam Rose, William Sabol, and Eric Sevigny; we also had input from ONDCP staff, including Fe Caces, Michael Cala, and Terry Zobeck. Disclaimer The information and opinions expressed herein are the views of the authors and do not necessarily represent the views of the Office of National Drug Control Policy or any other agency of the Federal Government. Notice This report may be reproduced in whole or in part without permission from ONDCP. Citation of the source is appreciated. The suggested citation is: Office of National Drug Control Policy (2013). Improving the Measurement of Drug- Related Crime. Washington, DC: Executive Office of the President. Electronic Access to Publication This document can be accessed electronically through the following World Wide Web address: http://www.whitehouse.gov/ondcp Originating Office Executive Office of the President Office of National Drug Control Policy Washington, DC 20503 October 2013 ii Executive Summary S.1. -
Medical Marijuana: the Impact on the Workplace
9/1/2020 MEDICAL MARIJUANA: THE IMPACT ON THE WORKPLACE John A. McCreary Charlotte Katzenmoyer Adam L. Santucci Babst Calland Executive Director McNees Wallace & Nurick Phone: (412)394.5400 Capital Region Water Phone: (717)237.5388 [email protected] [email protected] [email protected] www.McNeesLaw.com OVERVIEW • The federal landscape • How the PA Medical Marijuana Law Works • Employment aspects of PA Medical Marijuana Law • What have the courts said (so far) www.McNeesLaw.com 1 9/1/2020 THE FEDERAL LANDSCAPE Marijuana ‐ Status Across the U.S. • Legal for recreational use –11 states plus DC • Legal for medical use –33 states plus DC • Low THC/High CBD laws –14 states • Federal Law • Controlled Substances Act (CSA) – Schedule I drug • DOJ Memo • Rohrabacher‐Farr/Blumenauer amendment • Farm Bill – legalization of hemp www.McNeesLaw.com THE FEDERAL LANDSCAPE Drug Free Workplace Act of 1988 • Applies to Federal contractors and grantees • Requires covered organizations to provide a “drug‐free workplace” by: • Publishing a policy statement • Establishing an awareness program • Notifying employees of their obligations • Notifying the granting agency of any violations • Imposing penalties • Standard – “good faith effort to maintain a drug‐free workplace.” • Penalties for lack of compliance –payments and/or grant may be suspended/terminated www.McNeesLaw.com 2 9/1/2020 MEDICAL MARIJUANA & DRUG TESTING Does Legalization Affect Drug Testing? • Testing generally governed by federal law • DOT Regulations • -
STU-1002 – Alcohol, Tobacco and Other Drug Policy
UNIVERSITY OF RICHMOND Policy Manual Policy #: STU-1002 Policy Title: Alcohol, Tobacco and Other Drug Policy Effective: 08/01/2021 Responsible Office: Compliance & Title IX Date Approval: Vice President for Student Development Approved: Replaces 07/01/2020 Responsible Deputy Title IX Coordinator for Students & Policy Dated: University Official: Substance Misuse Education and Prevention Coordinator PURPOSE: In accordance with the Drug Free Schools and Communities Act and its implementing regulations, the University of Richmond is required to communicate the following information regarding unlawful possession, use or distribution of alcohol, tobacco and illegal drugs to its students and employees. The purpose of this policy is to protect the health, safety and welfare of the members of the University community and the public served by the University. SCOPE: The Alcohol, Tobacco and Other Drug Policy applies to all students, staff, and faculty as well as third party users of University facilities. This policy applies to conduct that occurs on the campus of the University, on or in off-campus buildings or property of the University and at University sponsored activities, including off- campus education programs and activities and public property adjacent to the University. This policy also applies to University students studying abroad through a University approved study abroad program. INDEX: 1002.1................Policy & Rules 1002.2................Alcohol Policy 1002.3................Tobacco Policy University of Richmond | 1 STU-1002 – Alcohol, Tobacco and Other Drug Policy 1002.4 ….......... Marijuana Policy 1002.5................Drug Policy 1002.6................Sanctions for Alcohol, Tobacco and Other Drugs 1002.7................Federal and Commonwealth of Virginia Penalties 1002.8................Prevention and Education 1002.9................Health Risks 1002.10..............Resources POLICY STATEMENT: 1002.1 – Policy & Rules The University or Richmond strives to achieve a healthy living, learning and work environment.